Neuropsychopharmacology
- Effect of caffeine and cannabidiol (CBD) co-administration on Δ9-tetrahydrocannabinol (Δ9-THC) subjective effects, performance impairment, and pharmacokinetics12 months ago
- The exposome and the developing adolescent brain: understanding mechanisms of neuroplasticity12 months ago
- Standing firm: a lived experience perspective on Tourette’s Syndrome12 months ago
- Brainwaves meet soundwaves: ultrasound stimulation for treating major depressive disorder by targeting the subcallosal cingulate cortex12 months ago
- N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences1 year ago
- Connectome harmonics: a novel method exploring the psychedelic experience1 year ago
- Motor signs in late life depression relate to altered subcortical synaptic density and gray matter volume: an 11C-UCB-J PET-MR study1 year ago
Journal of Psychopharmacology
- Antipsychotic medication in people with intellectual disability and schizophrenia: A 25-year updated systematic review and cross-sectional study2 years ago
- Navigating the challenge of patient selection and scales to measure outcomes in ketamine trials for treatment-resistant depression2 years ago
- Safety, tolerability and pharmacokinetics of the phosphodiesterase 2 inhibitor BI 474121: An overview of phase I randomized trials in healthy volunteers2 years ago
- Blackcurrant (Ribes nigrum L.) improves cholinergic signaling and protects against chronic Scopolamine-induced memory impairment in mice2 years ago
- Long-read sequencing of CYP2D6 may improve psychotropic prescribing and treatment outcomes: A systematic review and meta-analysis2 years ago
- Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 × 2 factorial design, randomised controlled comparison with simvastatin2 years ago
- Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression?2 years ago
European Neuropsychopharmacology
- Psychological symptoms after awake deep brain stimulation surgery in parkinson’s disease, essential tremor, and dystonia2 years ago
- GLP-1 receptor agonists: A revolution in the treatment of Parkinson’s disease?2 years ago
- Social dysfunction relates to shifts within socioaffective brain systems among Schizophrenia and Alzheimer’s disease patients2 years ago
- Paid MBP advert_May 37TH_ECNP_CONGRESS_SPEAKERS2 years ago
- Paid MBP advert_May CALENDAR_OF_MEETINGS2 years ago
- Editorial Board2 years ago
- The clinical perspective on late-onset depression in European real-world treatment settings2 years ago